Miami, FL -- October 26, 2020 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD) (“Progressive Care” or the “Company”), a personalized
healthcare services and technology company, is pleased to announce
that its Board of Directors has appointed Alan Jay Weisberg as
Chief Executive Officer, effective October 15, 2020. Mr. Weisberg,
the Chairman of the Company’s Board of Directors, had served as the
Company’s interim Chief Executive Officer since August 2020, and as
the Company’s Chairman of the Board of Directors since October
2010.
Mr. Weisberg has been the Chief Financial Officer of QuikByte
Software, Inc., Chief Financial Officer of Getting Ready Corp., and
Chief Financial Officer of Longfoot Communications Corp., and has
more than thirty years of accounting experience. He is a principal
in Weisberg and Company, a Boca Raton, Florida, accounting firm,
and has served as an adjunct professor of introductory finance at
Florida International University.
“I am very excited to lead Progressive Care on a permanent basis
as we enter the next phase of our growth as an integrated,
technology-driven healthcare services company,” said Mr. Weisberg.
“We are working simultaneously on multiple fronts to dramatically
expand our reach and relevance, while cultivating multiple sources
of sustainable recurring revenue.”
“We continue to work toward the completion of the integration of
CallingDr™ telehealth service app,” continued Mr. Weisberg, “and we
are pursuing regulatory approval to expand our prescription drug
mail-order service from the current 14 states to all 50, a move
which we estimate will increase our total addressable market by
more than $200 billion.”
The Company is also pleased to announce that Cecile Munnik has
been appointed Chief Financial Officer, effective October 15, 2020.
Ms. Munnik has served as the Company’s Director of Finance and
Accounting since July 2020. Ms. Munnik has over fifteen years of
accounting and finance experience and has served in finance and
accounting leadership positions for companies and business units
with annual revenues ranging from $100M to $3B. Prior to joining
the Company, Ms. Munnik served as Director of Asset Management at
Unified Women’s Healthcare, Director of Finance at The Service
Companies and Manager of Financial Planning and Analysis at Lennox
International.
“I am thrilled to be assuming more responsibility as the Company
transitions into a multifaceted entity,” said Ms. Munnik. “I have
great admiration for the team at Progressive Care, and I look
forward to executing on the Company’s financial priorities to
enhance value for all of our stakeholders.”
“It’s not hyperbole to say that this is the most exciting time
for the Company since I first became involved ten years ago,” said
Mr. Weisberg further. “We believe our growth trajectory has the
potential to accelerate significantly in the coming years, which
will translate into greater value for our shareholders.”
For more information about Progressive Care, please visit the
company’s website:
https://www.ProgressiveCareUS.com
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo Rx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care Inc.
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding our planned expansion of the mail order services, the
size of our addressable market, integration of the CallingDr app
and the pace of our growth. When used herein, the words
“anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,”
“intend” and “expect” and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties and other factors that could cause the Company’s
actual results, performance, prospects and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2023 to Apr 2024